The genetics of amyotrophic lateral sclerosis
- PMID: 38967083
- PMCID: PMC11377058
- DOI: 10.1097/WCO.0000000000001294
The genetics of amyotrophic lateral sclerosis
Abstract
Purpose of review: Amyotrophic lateral sclerosis (ALS) has a strong genetic basis, but the genetic landscape of ALS appears to be complex. The purpose of this article is to review recent developments in the genetics of ALS.
Recent findings: Large-scale genetic studies have uncovered more than 40 genes contributing to ALS susceptibility. Both rare variants with variable effect size and more common variants with small effect size have been identified. The most common ALS genes are C9orf72 , SOD1 , TARDBP and FUS . Some of the causative genes of ALS are shared with frontotemporal dementia, confirming the molecular link between both diseases. Access to diagnostic gene testing for ALS has to improve, as effective gene silencing therapies for some genetic subtypes of ALS are emerging, but there is no consensus about which genes to test for.
Summary: Our knowledge about the genetic basis of ALS has improved and the first effective gene silencing therapies for specific genetic subtypes of ALS are underway. These therapeutic advances underline the need for better access to gene testing for people with ALS. Further research is needed to further map the genetic heterogeneity of ALS and to establish the best strategy for gene testing in a clinical setting.
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
Figures


Similar articles
-
Seeding activity of human superoxide dismutase 1 aggregates in familial and sporadic amyotrophic lateral sclerosis postmortem neural tissues by real-time quaking-induced conversion.Acta Neuropathol. 2024 Jun 17;147(1):100. doi: 10.1007/s00401-024-02752-8. Acta Neuropathol. 2024. PMID: 38884646 Free PMC article.
-
Reduced penetrance of gene variants causing amyotrophic lateral sclerosis.J Med Genet. 2024 Feb 21;61(3):294-297. doi: 10.1136/jmg-2023-109580. J Med Genet. 2024. PMID: 38123999
-
TARDBP-Related Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.2009 Apr 23 [updated 2023 Jan 5]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2009 Apr 23 [updated 2023 Jan 5]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301761 Free Books & Documents. Review.
-
Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis.Mol Neurodegener. 2025 May 15;20(1):58. doi: 10.1186/s13024-025-00838-9. Mol Neurodegener. 2025. PMID: 40375307 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
Cited by
-
N-Terminal Fragments of TDP-43-In Vitro Analysis and Implication in the Pathophysiology of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.Genes (Basel). 2024 Sep 1;15(9):1157. doi: 10.3390/genes15091157. Genes (Basel). 2024. PMID: 39336748 Free PMC article.
-
Glycerophospholipids in ALS: insights into disease mechanisms and clinical implication.Mol Neurodegener. 2025 Jul 26;20(1):85. doi: 10.1186/s13024-025-00876-3. Mol Neurodegener. 2025. PMID: 40713843 Free PMC article. Review.
-
RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights.Mol Neurodegener. 2025 Jun 4;20(1):64. doi: 10.1186/s13024-025-00851-y. Mol Neurodegener. 2025. PMID: 40468389 Free PMC article. Review.
-
Prevalence and impact of comorbidities in amyotrophic lateral sclerosis.J Neural Transm (Vienna). 2025 Jun 14. doi: 10.1007/s00702-025-02971-7. Online ahead of print. J Neural Transm (Vienna). 2025. PMID: 40515812 Review.
-
Kv3 channel agonist ameliorates the phenotype of a mouse model of amyotrophic lateral sclerosis.Acta Neuropathol Commun. 2025 Jul 14;13(1):153. doi: 10.1186/s40478-025-02067-z. Acta Neuropathol Commun. 2025. PMID: 40653481 Free PMC article.
References
-
- Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 2007; 6:994–1003. - PubMed
-
- Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362:59–62. - PubMed
-
- Al-Chalabi A, van den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol 2017; 13:96–104. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous